Rifampin Capsule Shortage: Supply Updates and Manufacturer Discontinuations

What’s in Shortage

Rifampin capsules, an anti-infective medication also known by the brand name RIFAMPIN, are currently listed in a shortage status. This affects both 150 mg and 300 mg dosage forms. While some specific package sizes remain available, several others have been discontinued by the manufacturer. This shortage has been active since December 2021 and was most recently updated in February 2026.

Which Manufacturers Are Affected

Epic Pharma, LLC

• Status: Limited Availability / Partial Discontinuation
• Available Presentations:
  • Rifampin, Capsule, 300 mg (NDC 42806-799-60)
  • Rifampin, Capsule, 150 mg (NDC 42806-801-30)
• Unavailable Presentations (Discontinued):
  • Rifampin, Capsule, 300 mg (NDC 42806-799-30)
  • Rifampin, Capsule, 300 mg (NDC 42806-799-05)
  • Rifampin, Capsule, 300 mg (NDC 42806-799-01)
  • Rifampin, Capsule, 150 mg (NDC 42806-801-01)
• Contact Information: (718) 276-8600 ext. 3

Why There’s a Shortage

The current shortage is due to the discontinuation of the manufacture of specific drug presentations by Epic Pharma, LLC.

What Patients Should Do

If you are currently prescribed Rifampin, it is important to check your supply and speak with your healthcare provider or pharmacist. Because some package sizes (NDCs) are still available while others are discontinued, your pharmacy may need to source a different package size than what you have previously received.

• Consult your healthcare provider: Discuss your treatment plan and ensure you have a continuous supply of medication.
• Speak with your pharmacist: They can check current stock levels and verify which presentations are currently in stock.
• Contact the manufacturer: For specific supply questions, you can reach Epic Pharma, LLC at (718) 276-8600 ext. 3.

Disclaimer: Patients should always consult their healthcare provider regarding their treatment and any potential changes to their medication regimen. This article is for informational purposes only and does not constitute medical advice.

Source

Information provided by the FDA Drug Shortage Database. Initial Posting Date: 12/22/2021 Last Updated: 02/04/2026